Article citationsMore>>

Hickson, L.J., LanghiPrata, L.G.P., Bobart, S.A., Evans, T.K., Giorgadze, N., Hashmi, S.K., Herrmann, S.M., Jensen, M.D., Jia, Q., Jordan, K.L., Kellogg, T.A., Khosla, S., Koerber, D.M., Lagnado, A.B., Lawson, D.K., LeBrasseur, N.K., Lerman, L.O., McDonald, K.M., McKenzie, T.J., Passos, J.F., Pignolo, R.J., Pirtskhalava, T., Saadiq, I.M., Schaefer, K.K., Textor, S.C., Victorelli, S.G., Volkman, T.L., Xue, A., Wentworth, M.A., Wissler Gerdes, E.O., Zhu, Y., Tchkonia, T. and Kirkland, J.L. (2019) Senolytics Decrease Senescent Cells in Humans: Preliminary Report from a Clinical trial of Dasatinib plus Quercetin in Individuals with Diabetic Kidney Disease. Ebiomedicine, 47, 446-456.
https://doi.org/10.1016/j.ebiom.2019.08.069

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top